Novavax stock jumps after company settles dispute over canceled Covid vaccine purchase
Publishing timestamp: 2024-02-22 11:14:13
Summary
Novavax settles arbitration dispute with Gavi over canceled Covid vaccine purchase agreement, potentially paying up to $475 million. Settlement eliminates uncertainty around Novavax's future and allows Gavi to order more shots over the next five years. Novavax's business outlook could improve as a result of the settlement.
Sentiment: NEUTRAL
Tickers: NVAX,
Keywords: biotech and pharmaceuticals, health care industry, business news, biotechnology, breaking news, pharmaceuticals, novavax inc, business,